1. Home
  2. KOSS vs VNRX Comparison

KOSS vs VNRX Comparison

Compare KOSS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • VNRX
  • Stock Information
  • Founded
  • KOSS 1953
  • VNRX N/A
  • Country
  • KOSS United States
  • VNRX United States
  • Employees
  • KOSS N/A
  • VNRX N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • KOSS Consumer Staples
  • VNRX Health Care
  • Exchange
  • KOSS Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • KOSS 49.1M
  • VNRX 69.7M
  • IPO Year
  • KOSS N/A
  • VNRX N/A
  • Fundamental
  • Price
  • KOSS $5.08
  • VNRX $0.44
  • Analyst Decision
  • KOSS
  • VNRX Strong Buy
  • Analyst Count
  • KOSS 0
  • VNRX 4
  • Target Price
  • KOSS N/A
  • VNRX $3.50
  • AVG Volume (30 Days)
  • KOSS 57.1K
  • VNRX 935.0K
  • Earning Date
  • KOSS 10-28-2025
  • VNRX 11-13-2025
  • Dividend Yield
  • KOSS N/A
  • VNRX N/A
  • EPS Growth
  • KOSS N/A
  • VNRX N/A
  • EPS
  • KOSS N/A
  • VNRX N/A
  • Revenue
  • KOSS $12,624,170.00
  • VNRX $1,319,252.00
  • Revenue This Year
  • KOSS N/A
  • VNRX $324.32
  • Revenue Next Year
  • KOSS N/A
  • VNRX $247.82
  • P/E Ratio
  • KOSS N/A
  • VNRX N/A
  • Revenue Growth
  • KOSS 2.93
  • VNRX 35.10
  • 52 Week Low
  • KOSS $4.00
  • VNRX $0.40
  • 52 Week High
  • KOSS $8.59
  • VNRX $0.94
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 47.80
  • VNRX 33.78
  • Support Level
  • KOSS $4.85
  • VNRX $0.43
  • Resistance Level
  • KOSS $5.21
  • VNRX $0.48
  • Average True Range (ATR)
  • KOSS 0.29
  • VNRX 0.04
  • MACD
  • KOSS 0.04
  • VNRX -0.00
  • Stochastic Oscillator
  • KOSS 43.88
  • VNRX 9.60

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: